| Hans-Günter Meyer-Thompson | Legal
USA – Naltrexone for extended-release injectable suspension. Seizing on Opioid Crisis, a Drug Maker Lobbies Hard for Its Product
The ads have been popping up on billboards, buses and subways and in glossy magazines, with portraits of attractive men and women and a simple question in bold letters: What is Vivitrol?
Five years ago, Vivitrol was a treatment for opioid addiction that was struggling to find a market. Now, its sales and profile are rising fast, thanks to its manufacturers’ shrewd use of political connections, and despite scant science to prove the drug’s efficacy. (New York Times, 11.06.2017)
https://www.nytimes.com/2017/06/11/health/vivitrol-drug-opioid-addiction.html